China to accept overseas trial data in bid to speed up drug approvals

The Cabinet also said it would look to improve the protection of medical intellectual property and boost the number and quality of clinical trial testing centers in China. The proposals contained no timeline for implementation. “We want to make our drug …
( read original story …)